Company Filing History:
Years Active: 2018-2021
Title: David Keys: Innovator in Karyotyping and Digital PCR
Introduction
David Keys, an accomplished inventor based in Alameda, CA, has made significant contributions to the field of biotechnology with a total of four patents to his name. His innovative work primarily focuses on methods and systems that enhance the accuracy and effectiveness of genomic analysis, addressing critical areas in biological research and diagnostics.
Latest Patents
Among his latest patents, David has developed a Karyotyping Assay, which pertains to methods and kits for analyzing chromosomes by amplifying loci outside of copy number variable regions. This advancement is vital for genetic research and diagnostics, providing more reliable karyotyping results. Additionally, he has innovated systems and methods for performing digital PCR, a technique that quantifies target nucleic acids. This process involves segregating a sample into multiple reaction volumes to ascertain the presence of target nucleic acid molecules, followed by an amplification assay that effectively measures the target's quantity through indicators enhanced by amplification.
Career Highlights
David currently works at Life Technologies Corporation, a prominent company in the biotechnology sector. His role enables him to apply his expertise in innovative technologies related to nucleic acid measurement and characterization.
Collaborations
Throughout his career, David has collaborated with notable professionals in the industry, including Caifu Chen and Adam Broomer. These collaborations have fostered an environment of creativity and innovation, allowing him to enhance his inventions and expand the scope of his research efforts.
Conclusion
David Keys stands out as a visionary inventor in the realm of biotechnological innovations. His contributions to karyotyping and digital PCR not only signify his dedication to advancing scientific research but also highlight the importance of collaboration in achieving groundbreaking results. His ongoing work with Life Technologies Corporation promises to pave the way for future innovations in genetics and molecular biology.